| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.83B | 40.34B | 35.59B | 34.54B | 35.10B | 31.88B |
| Gross Profit | 6.83B | 7.83B | 6.46B | 6.13B | 5.51B | 4.74B |
| EBITDA | 2.15B | 2.58B | 1.99B | 1.76B | 1.38B | 979.00M |
| Net Income | 1.70B | 1.97B | 1.53B | 1.37B | 1.04B | 749.00M |
Balance Sheet | ||||||
| Total Assets | 43.14B | 45.95B | 43.97B | 43.34B | 43.73B | 43.30B |
| Cash, Cash Equivalents and Short-Term Investments | 5.24B | 4.38B | 5.09B | 4.86B | 3.40B | 4.42B |
| Total Debt | 1.38B | 500.00M | 534.00M | 535.00M | 1.59B | 2.90B |
| Total Liabilities | 12.09B | 13.22B | 13.04B | 13.53B | 15.51B | 15.85B |
| Stockholders Equity | 31.05B | 32.73B | 30.93B | 29.81B | 28.22B | 27.45B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 568.00M | 397.00M | 2.72B | 497.00M | 1.34B |
| Operating Cash Flow | 0.00 | 2.25B | 1.45B | 3.20B | 756.00M | 1.57B |
| Investing Cash Flow | 0.00 | -1.59B | -805.00M | -297.00M | -161.00M | 547.00M |
| Financing Cash Flow | 0.00 | -1.37B | -404.00M | -1.38B | -1.61B | -1.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥434.26B | 12.05 | ― | 3.26% | -6.84% | 4.65% | |
74 Outperform | ¥16.45B | 9.20 | ― | 2.73% | 13.36% | 29.00% | |
72 Outperform | ¥46.11B | 6.29 | ― | 6.31% | -12.17% | -23.60% | |
65 Neutral | ¥12.28B | 7.37 | ― | 3.84% | -0.71% | -16.69% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | ¥78.83B | 13.13 | ― | 3.70% | -2.40% | -8.59% | |
55 Neutral | ¥35.35B | 13.50 | ― | 5.02% | -12.42% | -56.79% |